Overview of the Quality of Life of Breast Cancer Patients Undergoing Chemotherapy During the COVID-19 Pandemic
DOI:
https://doi.org/10.35451/jkf.v4i2.986Keywords:
Quality of life, Chemotherapy, Pandemic COVID-19Abstract
Chemotherapy as an option for breast cancer treatment. The Covid-19 pandemic has had a serious impact on health services, one of which is chemotherapy services. The delay in chemotherapy services due to the increasing number of COVID-19 cases indirectly has an impact on the quality of life of breast cancer patients undergoing chemotherapy. The purpose of this study was to describe the quality of life of breast cancer patients undergoing chemotherapy during the COVID-19 pandemic. The design of this study used a quantitative descriptive with a cross sectional design. The study was conducted in the Chemotherapy Room Sanjiwani RSUP Sanglah with a sample size of 50 respondents with a sampling technique using purposive sampling. The results of this study indicate that the majority of breast cancer patients have quality of life in the moderate category as many as 47 respondents (96%) with an average quality of life score of 649.45 in the moderate category. Moderate quality of life in cancer patients is due to chemotherapy which improves the patient’s healing process so that there is an increase in quality of life. It is hoped that health workers will receive IEC and motivation for breast cancer patients undergoing chemotherapy during the COVID-19 pandemic as an effort to improve the patient's quality of life
Downloads
References
ACS, A. C. S. (2015). Caring for patient with cancer at home: A guide for patients and familie. Atlanta: American Cancer Society.
Agustini, D. (2015). Kualitas Hidup Pasien Kanker Payudara dengan Terapi Kombinasi Fluorouracil, Doxorobicin dan Cyclofosfamide. Jurnal Farmasi Klinik Indonesia, 4 (3), 175–185.
Ashariati, A. (2019). Manajemen Kanker Payudara Komprehensif. Surabaya: Univeritas Airlangga.
Chean, D. C. (2016). Health Related Quality of Life (HRQoL) Among Breast Cancer Patients Receving Chemotherapy in Hospital Melaka. Journal of Cancer Prevention, 17 (12)(5121–6).
Dewi, A. P. (2020). Hubungan antara Frekuensi Kemoterapi dan Status Nutrisi Pasien Kanker yang Menjalani Kemoterapi di Ruang Sanjiwani RSUP Sanglah Denpasar. Community of Publishing In Nursing (COPING), 8 (3)(2715–1980), 258–267.
Dinas Kesehatan Provinsi Bali. (2021). Profil Kesehatan Provinsi Bali. Denpasar. Diambil dari https://www.diskes.baliprov.go.id/profil-kesehatan-provinsi-bali
Friedman. (2013). Keperawatan Keluarga. Yogyakarta: Gosyen Publising.
Juwita, D. A. (2019). Penilaian Kualitas Hidup Terkait Kesehatan Pasien Kanker Payudara di RSUP Dr. M. Djamil Padang, Indonesia. Jurnal Ilmu Kefarmasian Indonesia, 17 (1)(2614–6495), 114–119. Diambil dari https://jifi.farmasi.univpancasila.ac.id
Kemenkes RI. (2019). Panduan Penatalaksanaan Kanker Payudara. Jakarta: Kemenkes RI.
Maria, Y. (2016). Kualitas Hidup Pasien Kanker yang Menjalani Kemoterapi. Jurnal Kesehatan Masyarakat, 1 (1). Diambil dari https://journal.stikessuakainsan.ac.id
Rahayu, S. M. (2020). Kualitas Hidup Pasien Kanker Yang Menjalani Kemoterapi di Bandung Cancer Society. Jurnal Wacana Kesehatan, 5 (2)(2544–6251), 551–566. Diambil dari https://jurnal.akperdharmawacana.ac.id
Ratih, K. D. (2020). Hubungan Kepatuhan Menjalani Kemoterapi dengan Kualitas Hidup Pasien Kanker Payudara di RSUD dr.Moewardi Surakarta. Jurnal Ilmiah Kesehatan Masyarakat, 12 (4), 154–163.
Riskesdas. (2018). Laporan Hasil Riset Kesehatan Dasar (Riskesdas) Indonesia tahun 2018. Riset Kesehatan Dasar 2018.
Rosyanti, L. (2018). E-Book: Memahami Gangguan Depresi Mayor (Major Depressive Disorder). Kendari: Poltekes Kendari.
Sun, Y. S. (2017). Risk Faktor and Prevention of Breast Cancer. International Journal of Biological Sciences, 13 (11)(1387–1397).
Tunas, I. K. (2016). Penilaian Kualitas Hidup Pasien Kanker Servik dengan Kemoterapi Paklitasel-Karboplatin di RSUP Sanglah. Jurnal Farmasi Klinik Indonesia, 5 (1), 35–46.
Vos, F. (2014). Paclitaxel and Carboplatin Concurrent with Radiotherapy for Primary Cervical Cancer. New York: Oxford University Press.
Downloads
Published
How to Cite
Issue
Section
License
Copyright in each article is the property of the Author.
